These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16765816)

  • 1. Vigamox: how good is its self-preservation?
    Haas MG; Yung CW; Chaluvadi U; Davis TE
    J Cataract Refract Surg; 2006 May; 32(5):899-900. PubMed ID: 16765816
    [No Abstract]   [Full Text] [Related]  

  • 2. In-use study of potential bacterial contamination of ophthalmic moxifloxacin.
    Mason BL; Alfonso EC; Miller D
    J Cataract Refract Surg; 2005 Sep; 31(9):1773-6. PubMed ID: 16246782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 2: residual conjunctival flora.
    Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
    J Cataract Refract Surg; 2008 Aug; 34(8):1383-8. PubMed ID: 18655992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial contamination of preservative free eye drops in multiple application containers.
    Rahman MQ; Tejwani D; Wilson JA; Butcher I; Ramaesh K
    Br J Ophthalmol; 2006 Feb; 90(2):139-41. PubMed ID: 16424520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of pharmaceuticals by the ampholyte dodecyldi-(aminoethyl)glycine.
    Pilling M; Brown MW; Ford JL
    Pharm Acta Helv; 1987; 62(3):73-80. PubMed ID: 3588642
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacterial contamination of multi-dose ocular solutions. A prospective study at the Grenoble Teaching Hospital].
    Brudieu E; Duc DL; Masella JJ; Croize J; Valence B; Meylan I; Mouillon M; Franco A; Calop J
    Pathol Biol (Paris); 1999 Dec; 47(10):1065-70. PubMed ID: 10674260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues in the use of preservative-free topicals.
    Perry HD; Donnenfeld ED
    Manag Care; 2003 Dec; 12(12 Suppl):39-41. PubMed ID: 14723113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy trial of the antimicrobial preservation of pharmaceutical preparations. 3d joint report of the Committee for Laboratories and Official Services for the Control of Drugs and the Section of Industrial Pharmacists--International Pharmacy Federation, June 1979].
    Pharm Acta Helv; 1979; 54(12):370-9. PubMed ID: 395540
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence-based review of moxifloxacin.
    O'Brien TP
    Int Ophthalmol Clin; 2006; 46(4):61-72. PubMed ID: 17060792
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ophthalmic preservatives and preparations: reality and perspectives].
    Chibret H
    Ann Pharm Fr; 1997; 55(5):228-31. PubMed ID: 9406473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial contamination of ophthalmic solutions used in an extended care facility.
    Jokl DH; Wormser GP; Nichols NS; Montecalvo MA; Karmen CL
    Br J Ophthalmol; 2007 Oct; 91(10):1308-10. PubMed ID: 17475711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Preservatives" in propofol.
    Craig DB
    Can J Anaesth; 1998 Sep; 45(9):913. PubMed ID: 9818119
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis.
    Lane SS; Stroman DW; Cockrum P
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):571; author reply 573-5. PubMed ID: 20028267
    [No Abstract]   [Full Text] [Related]  

  • 14. Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers.
    Kim MS; Choi CY; Kim JM; Chang HR; Woo HY
    Br J Ophthalmol; 2008 Nov; 92(11):1518-21. PubMed ID: 18782802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proper hygiene involving preparations for personal hygiene, personal care and improvement of face and body from the bacteriological aspect].
    Kupinić M; Dermelj-Rajer V
    Nar Zdrav; 1976; 32(5-6):240-5. PubMed ID: 1030468
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bacteriologic evaluation of ophthalmic methylcellulose preparations prepared at the hospital].
    Irkeç M; Yuluğ A
    Mikrobiyol Bul; 1988; 22(3):235-7. PubMed ID: 3252115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterility-testing program for antibiotics and other intravenous admixtures.
    Choy FN; Lamy PP; Burkhart VD; Tenney JH
    Am J Hosp Pharm; 1982 Mar; 39(3):452-6. PubMed ID: 7041640
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacteriological control of collyria.
    Papavassiliou J; Albalas B; Zouroudis N; Chitiroglou-Lada K; Siouti M
    Pharm Acta Helv; 1977; 52(12):293-5. PubMed ID: 615315
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
    Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
    J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for evaluating the effectiveness of preservative systems in water-immiscible ointments.
    Abshire RL; Schlech BA
    J Parenter Sci Technol; 1982; 36(5):216-21. PubMed ID: 6765553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.